Papers: 10.1016/S1470-2045(19)30569-8
https://doi.org/10.1016/S1470-2045(19)30569-8
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Cited by: 320
Author(s): D. Brand, A. Tree, Peter Ostler, H. van der Voet, Andrew Loblaw, William Chu, Daniel Ford, Shaun Tolan, Suneil Jain, Alexander S. Martin, John Staffurth, Philip Camilleri, Kiran Kancherla, J. Frew, Andrew Chan, Ian S. Dayes, Daniel R. Henderson, Stephanie Brown, Clare Cruickshank, Stephanie M. Burnett, A. Duffton, Clare Griffin, Victoria Hinder, Kirsty Morrison, O. Naismith, Emma Hall, Nicholas van As, D. Dodds, Éric Lartigau, Suzanne E. Patton, Alan Thompson, Mathias Winkler, Paula Wells, Timothy Lymberiou, Deanna Saunders, Maria Vilarino-Varela, Peter Vavassis, Theodoros Tsakiridis, R Carlson, George Rodrigues, Jean François Tanguay, Shahid Iqbal, Scott C. Morgan, Alina Mihai, A Li, Omar Din, Miguel Panades, Ros Wade, Y. Rimmer, John G. Armstrong, Nikhil Babu Oommen
Published: about 7 years ago